clinical
Akelos receives NIH grant to continue research on nonopioid alternative for neuropathic pain
The therapy would be based on a molecule that selectively blocks an ion channel protein that can become overactive in peripheral neuropathic pain.
By ADA News ·
The therapy would be based on a molecule that selectively blocks an ion channel protein that can become overactive in peripheral neuropathic pain.